Mevalonate metabolism in cancer

This publication has 52 references indexed in Scilit:

• Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway
  Cell, 2012
• Hallmarks of Cancer: The Next Generation
  Cell, 2011
• Dysregulation of the mevalonate pathway promotes transformation
  Proceedings of the National Academy of Sciences, 2010
• In vivo manipulation of Vγ9Vδ2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients
  Clinical and Experimental Immunology, 2010
• Mutant p53 Gain-of-Function in Cancer
  Cold Spring Harbor Perspectives in Biology, 2009
• Isopentenyl Pyrophosphate–Activated CD56+ γδ T Lymphocytes Display Potent Antitumor Activity toward Human Squamous Cell Carcinoma
  Clinical Cancer Research, 2008
• Amino-Biphosphonate–Mediated MMP-9 Inhibition Breaks the Tumor-Bone Marrow Axis Responsible for Myeloid-Derived Suppressor Cell Expansion and Macrophage Infiltration in Tumor Stroma
  Cancer Research, 2007
• Live or let die: the cell's response to p53
  Nature Reviews Cancer, 2002
• The Hallmarks of Cancer
  Cell, 2000
• Regulation of the mevalonate pathway
  Nature, 1990